SEATTLE — Retail veteran Kathi Lentzsch has been appointed chief executive officer of Bartell Drugs. She succeeds Brian Unmacht, who resigned last spring. Unmacht was the first person outside of the Bartell family to head the company. Lentzsch has more than three decades of retail experience, with executive positions in companies including Pier 1 Imports
SEATTLE — Retail veteran Kathi Lentzsch has been named chief executive officer of Bartell Drugs. She succeeds Brian Unmacht, who resigned last spring. Unmacht was the first person outside of the Bartell family to head the company. Lentzsch has more than three decades of retail experience with executive positions in companies including Pier 1 Imports and Cost
SEATTLE — After just two years on the job, Bartell Drugs chief executive officer Brian Unmacht has resigned. Bartell Drugs has confirmed a published report that Unmacht — the first person outside the Bartell family to hold the president and CEO title — resigned nearly two weeks ago. “Brian Unmacht resigned his position effective March 27